Division of Organ Transplantation, Department of Surgery, University of Massachusetts Medical School, Worcester, MA 01655, USA.
HPB (Oxford). 2012 Jul;14(7):455-60. doi: 10.1111/j.1477-2574.2012.00475.x. Epub 2012 May 11.
Living donor liver transplantation (LDLT) is an accepted treatment for patients with end-stage liver disease. To minimize risk to the donor, left lobe (LL) LDLT may be an ideal option in adult LDLT.
This study assessed the outcomes of LL-LDLT compared with right lobe (RL) LDLT in adults (1998-2010) as reported to the United Network for Organ Sharing (UNOS) Organ Procurement and Transplantation Network (OPTN).
A total of 2844 recipients of LDLT were identified. Of these, 2690 (94.6%) underwent RL-LDLT and 154 (5.4%) underwent LL-LDLT. A recent increase in the number of LL-LDLTs was noted: average numbers of LL-LDLTs per year were 5.2 during 1998-2003 and 19.4 during 2004-2010. Compared with RL-LDLT recipients, LL-LDLT recipients were younger (mean age: 50.5 years vs. 47.0 years), had a lower body mass index (BMI) (mean BMI: 24.5 kg/m(2) vs. 26.8 kg/m(2)), and were more likely to be female (64.6% vs. 41.9%). Donors in LL-LDLT had a higher BMI (mean BMI: 29.4 kg/m(2) vs. 26.5 kg/m(2)) and were less likely to be female (30.9% vs. 48.1%). Recipients of LL-LDLT had a longer mean length of stay (24.9 days vs. 18.2 days) and higher retransplantation rates (20.3% vs. 10.9%). Allograft survival in LL-LDLT was significantly lower than in RL-LDLT and there was a trend towards inferior patient survival. In Cox regression analysis, LL-LDLT was found to be associated with an increased risk for allograft failure [hazard ratio (HR): 2.39)] and inferior patient survival (HR: 1.86).
The number of LL-LDLTs has increased in recent years.
活体肝移植(LDLT)是治疗终末期肝病患者的一种公认的治疗方法。为了使供体的风险最小化,左叶(LL)LDLT 可能是成人 LDLT 的理想选择。
本研究评估了 1998 年至 2010 年向美国器官共享联合网络(UNOS)器官获取与移植网络(OPTN)报告的成人 LL-LDLT 与右叶(RL)LDLT 的结果。
共确定了 2844 例 LDLT 受者。其中,2690 例(94.6%)接受 RL-LDLT,154 例(5.4%)接受 LL-LDLT。注意到 LL-LDLT 的数量最近有所增加:1998 年至 2003 年每年平均 LL-LDLT 数量为 5.2 例,2004 年至 2010 年每年平均 LL-LDLT 数量为 19.4 例。与 RL-LDLT 受者相比,LL-LDLT 受者年龄更小(平均年龄:50.5 岁 vs. 47.0 岁),体重指数(BMI)较低(平均 BMI:24.5kg/m² vs. 26.8kg/m²),女性比例更高(64.6% vs. 41.9%)。LL-LDLT 供者的 BMI 较高(平均 BMI:29.4kg/m² vs. 26.5kg/m²),女性比例较低(30.9% vs. 48.1%)。LL-LDLT 受者的平均住院时间较长(24.9 天 vs. 18.2 天),再次移植率较高(20.3% vs. 10.9%)。LL-LDLT 的移植物存活率明显低于 RL-LDLT,患者存活率也呈下降趋势。在 Cox 回归分析中,LL-LDLT 与移植物衰竭风险增加相关[风险比(HR):2.39],且患者存活率较低(HR:1.86)。
近年来,LL-LDLT 的数量有所增加。